AMRYT PHARMA PLC - SPNR ADR (AMYT) Stock Price, Quote, News and Overview
NASDAQ:AMYT - Nasdaq - US03217L1061 - ADR - Currency: USD
AMYT Quote, Performance and Key Statistics
14.7
+0.01 (+0.07%)
The current stock price of AMYT is 14.7 USD. In the past month the price increased by 1.03%. In the past year, price increased by 86.55%.
AMYT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.44 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.58 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.78 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About AMYT
Company Profile
Amryt Pharma Plc is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The firm is focused on developing and commercialization of treatments for orphan and rare diseases patients. The Company’s commercial business provides orphan disease products, which includes Juxtapid/ Lojuxta and Myalept / Myalepta. The Company’s lead development candidate is FILSUVEZ.
Company Info
AMRYT PHARMA PLC - SPNR ADR
Ivybridge House, 1 Adam Street
London D02 CR98 GB
CEO: Dr. Joseph A. Wiley
Employees: 99
Company Website: https://www.amrytpharma.com/
Phone: 442034155730.0
AMRYT PHARMA PLC - SPNR ADR / AMYT FAQ
What is the stock price of AMRYT PHARMA PLC - SPNR ADR today?
The current stock price of AMYT is 14.7 USD. The price increased by 0.07% in the last trading session.
What is the ticker symbol for AMRYT PHARMA PLC - SPNR ADR stock?
The exchange symbol of AMRYT PHARMA PLC - SPNR ADR is AMYT and it is listed on the Nasdaq exchange.
On which exchange is AMYT stock listed?
AMYT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AMRYT PHARMA PLC - SPNR ADR stock?
7 analysts have analysed AMYT and the average price target is 36.48 USD. This implies a price increase of 148.2% is expected in the next year compared to the current price of 14.7. Check the AMRYT PHARMA PLC - SPNR ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AMRYT PHARMA PLC - SPNR ADR worth?
AMRYT PHARMA PLC - SPNR ADR (AMYT) has a market capitalization of 2.64B USD. This makes AMYT a Mid Cap stock.
How many employees does AMRYT PHARMA PLC - SPNR ADR have?
AMRYT PHARMA PLC - SPNR ADR (AMYT) currently has 99 employees.
What are the support and resistance levels for AMRYT PHARMA PLC - SPNR ADR (AMYT) stock?
AMRYT PHARMA PLC - SPNR ADR (AMYT) has a support level at 14.61 and a resistance level at 14.73. Check the full technical report for a detailed analysis of AMYT support and resistance levels.
Should I buy AMRYT PHARMA PLC - SPNR ADR (AMYT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AMYT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AMYT, evaluating the profitability, health, valuation and growth aspects
- AMRYT PHARMA PLC - SPNR ADR (AMYT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AMRYT PHARMA PLC - SPNR ADR (AMYT) Sales and EPS estimates to see what analysts future expectations are.
- AMRYT PHARMA PLC - SPNR ADR (AMYT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AMRYT PHARMA PLC - SPNR ADR (AMYT) Insider and Institutional Ownership to learn about the owners and their transactions.
- AMRYT PHARMA PLC - SPNR ADR (AMYT) Stock Chart to make your own analysis
- AMRYT PHARMA PLC - SPNR ADR (AMYT) Latest news and press-releases to stay up to date.
Does AMRYT PHARMA PLC - SPNR ADR (AMYT) stock pay dividends?
AMYT does not pay a dividend.
AMYT Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to AMYT. When comparing the yearly performance of all stocks, AMYT is one of the better performing stocks in the market, outperforming 96.95% of all stocks.
AMYT Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AMYT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to AMYT. The Buy consensus is the average rating of analysts ratings from 7 analysts.